Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Gains from Investment Securities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Gains from Investment Securities for 3 consecutive years, with $2.4 million as the latest value for Q1 2026.

  • Quarterly Gains from Investment Securities rose 3330.25% to $2.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.4 million through Jan 2026, up 3330.25% year-over-year, with the annual reading at $4.6 million for FY2025, N/A changed from the prior year.
  • Gains from Investment Securities for Q1 2026 was $2.4 million at Kestra Medical Technologies, down from $4.6 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $4.6 million in Q4 2025, with the low at -$130000.0 in Q2 2024.
  • Average Gains from Investment Securities over 3 years is $1.7 million, with a median of $915548.0 recorded in 2024.
  • Peak annual rise in Gains from Investment Securities hit 45493.0% in 2025, while the deepest fall reached 340.74% in 2025.
  • Over 3 years, Gains from Investment Securities stood at $915548.0 in 2024, then soared by 398.16% to $4.6 million in 2025, then tumbled by 46.3% to $2.4 million in 2026.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $2.4 million, $4.6 million, and $4.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.